Common-Size Income Statement
Quarterly Data
Paying user area
Try for free
Thermo Fisher Scientific Inc. pages available for free this week:
- Income Statement
- Cash Flow Statement
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Profitability Ratios
- Analysis of Liquidity Ratios
- Analysis of Long-term (Investment) Activity Ratios
- Price to FCFE (P/FCFE)
- Net Profit Margin since 2005
- Total Asset Turnover since 2005
- Price to Operating Profit (P/OP) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Thermo Fisher Scientific Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Based on: 10-Q (reporting date: 2026-06-27), 10-Q (reporting date: 2026-03-28), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-27), 10-Q (reporting date: 2025-06-28), 10-Q (reporting date: 2025-03-29), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-28), 10-Q (reporting date: 2024-06-29), 10-Q (reporting date: 2024-03-30), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-07-01), 10-Q (reporting date: 2023-04-01), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-10-01), 10-Q (reporting date: 2022-07-02), 10-Q (reporting date: 2022-04-02), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-10-02), 10-Q (reporting date: 2021-07-03), 10-Q (reporting date: 2021-04-03).
A significant strategic shift in the revenue composition is evident over the analyzed period. Product revenues, which initially constituted 79.31% of total revenues in April 2021, experienced a consistent decline, stabilizing between 57% and 59% by 2024 and 2025. Conversely, service revenues grew from 20.69% to consistently exceeding 40% starting in 2023, indicating a structural transition toward a more service-oriented business model.
- Gross Profitability and Cost Structure
- Gross profit margins underwent a period of contraction, falling from a peak of 52.58% in April 2021 to a low of 38.66% in April 2023. This decline is primarily attributed to the rising cost of service revenues, which increased from -13.83% to approximately -30% of total revenues. While the cost of product revenues remained relatively stable—fluctuating between -28% and -36%—the overall gross margin eventually stabilized in the 40% to 42% range throughout 2024 and 2025.
- Operating Expense Management
- Selling, general and administrative (SG&A) expenses have remained remarkably consistent, generally oscillating between 19% and 21% of revenues. Research and development (R&D) spending has also shown high stability, consistently representing approximately 3% of total revenues. Restructuring and other costs have been sporadic, with a notable peak of -2.01% in December 2024, though they typically remain below 1% of revenues.
- Operating and Net Income Trends
- Operating income margins mirrored the trend of gross profit, decreasing from 30.78% in early 2021 to a trough of 14.59% in April 2023. Following this decline, margins recovered and stabilized between 16% and 18% from late 2023 through 2026. Net income attributable to the company followed a similar trajectory, starting at 23.59% and stabilizing in the 14% to 16% range in the latter half of the period.
- Financial and Tax Obligations
- Interest income saw a marked increase, rising from 0.12% in 2021 to a peak of 2.84% in December 2023, before settling around 1.7% to 2.1%. This was accompanied by an increase in interest expenses, which grew from -1.26% to a peak of -3.72% in June 2025, suggesting an increase in leverage or higher borrowing costs. Provision for income taxes fluctuated significantly, showing a general trend of reduction from 4.20% in early 2021 to lower levels, frequently remaining below 1.5% in more recent quarters.
Overall, the financial profile reflects a transition from a product-heavy revenue stream with high margins to a balanced product-service mix with a more stabilized, albeit lower, margin profile. The consistency in SG&A and R&D spending indicates disciplined operational overhead management despite the shift in business composition.